RFA-IP-22-004:Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines
$1,400,000U01FY2024IPCDC
University Of Michigan At Ann Arbor, Ann Arbor MI
University Of Michigan At Ann Arbor, Ann Arbor MI